 |
 |
 |
 |
 |
|
|
|
| Article 1 to 10 out of 52
|
|
-
ChemAxon Announces New CEO and Head of R&D
(14 May 2008)
ChemAxon announced the appointment of Alex Drijver as CEO. The arrival signals the companies increased focus on business development and market position. Ferenc Csizmadia, founder and former CEO, moves to Chairman and Head of Research and ......
-
GeneBio Appoints Mark Pitman to Run North American Business Operations
(14 Apr 2008)
Geneva Bioinformatics (GeneBio) SA announced the hiring of Mark Pitman, formerly of Proteome Software, for the role of Sales and Business Director, North America. This newly created strategic position gives GeneBio an established presence in ......
-
Gerhard Schratt, PhD and Professor Albert Sickmann receive the Analytica Research Prize
(04 Apr 2008)
"There's nothing like starting young" - so goes the old German proverb. The truth of this saying is demonstrated by the two up-and-coming German scientists Dr. Gerhard Schratt (35) and Prof. Albert Sickmann (34). They will receive the 50,000 ......
-
caprotec bioanalytics GmbH Appoints Dr. Mathias Grote as Chief Financial and Chief Operating Officer
(18 Mar 2008)
caprotec bioanalytics GmbH announced the appointment of Dr. Mathias Grote as Chief Financial Officer and Chief Operating Officer of the Company. Before joining caprotec bioanalytics, Dr. Grote held various senior management positions within the ......
-
PerkinElmer Elects Patrick J. Sullivan as Director
(27 Feb 2008)
PerkinElmer, Inc. announced that Patrick J. Sullivan, Executive Chairman of Hologic, Inc., has been elected to the Company's Board of Directors. Sullivan brings extensive management experience in the diagnostic and medical device industries to ......
-
Fluorotechnics appoints Mark Weller to head up their UK Sales and Marketing operation
(22 Feb 2008)
Fluorotechnics announced the appointment of Mark Weller as head of their UK Sales team. According to the copmpany, Mark brings to Fluorotechnics a wealth of sales and technical experience, having served as a leading sales specialist and ......
-
NextGen Sciences Appoints New CEO and Expands Service Offering to Include Protein Biomarker Monitoring
(13 Nov 2007)
NextGen Sciences, provider of gene-to-protein products and services, has appointed Dr Mike Pisano as CEO, and has announced the expansion of its portfolio of services to include clinical protein biomarker monitoring. Dr Pisano joins the Company ......
-
LUX biotechnology announces appointments to Advisory Board
(12 Nov 2007)
LUX biotechnology limited (LUX), a specialist developer of light based detection technologies, announced that Mr Julian Cooper and Prof. Ian Collins have been unanimously appointed to its Advisory Board. Julian Cooper joins the Advisory Board ......
-
Lab21 appoints new CEO
(07 Nov 2007)
Lab21 has announced the appointment of Graham Mullis as its new CEO. Graham has held executive positions at FTSE and Nasdaq listed medical device companies including 1-800 Contacts Inc and Biocompatibles International PLC and pharmaceutical ......
-
Epigenomics AG Forms Medical Advisory Board for Colorectal Cancer Screening
(11 Oct 2007)
High-profile board to support Epigenomics in development and commercialization of its colorectal cancer screening test in the U.S.
Epigenomics AG announced the formation of its Colorectal Cancer Medical Advisory board and the appointment of its first four members. The board will advise Epigenomics on important aspects of the clinical development and commercialization ......
|
|
|